Novel Role of Molecular Hydrogen: The End of Ophthalmic Diseases?
Si-Yu Li, Rong-Yue Xue, Hao Wu, Ning Pu, Dong Wei, Na Zhao, Zong-Ming Song, Ye Tao · Pharmaceuticals (Basel, Switzerland) · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. Accumulating evidence suggest that H₂ is protective against multiple ophthalmic diseases, including cataracts, dry eye disease, diabetic retinopathy (DR) and other fields. It can be explained that just drinking water could cause parasympathetic nervous system stimulation, which may disrupt the functionality of Schlemm’s canal, ultimately resulting in an elevation of intraocular pressure [ 164 ].Current limitations in usage method, including special requirements for H₂ preparation and storage, as well as inconveniences and potential explosion risks, may hinder the widespread application of H₂. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. The endothelial cell density reduction rate in the H₂ group is significantly smaller compared with that observed in the control group at 1 day, 1 week and 3 weeks postoperatively.
What the Researchers Studied
The authors reviewed novel Role of Molecular Hydrogen: The End of Ophthalmic Diseases?.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen exposure: 420 mL hydrogen-rich water per reported dose; dissolved H₂ concentration was not sufficiently reported, so H2HUBB did not estimate milligrams of H₂. The endothelial cell density reduction rate in the H₂ group is significantly smaller compared with that observed in the control group at 1 day, 1 week and 3 weeks postoperatively. The authors concluded that accumulating evidence suggest that H₂ is protective against multiple ophthalmic diseases, including cataracts, dry eye disease, diabetic retinopathy (DR) and other fields.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen exposure was 420 mL hydrogen-rich water per reported dose; dissolved H₂ concentration was not sufficiently reported, so H2HUBB did not estimate milligrams of H₂.
Limitations and Safety
Reported limitations: It can be explained that just drinking water could cause parasympathetic nervous system stimulation, which may disrupt the functionality of Schlemm’s canal, ultimately resulting in an elevation of intraocular pressure [ 164 ].Current limitations in usage method, including special requirements for H₂ preparation and storage, as well as inconveniences and potential explosion risks, may hinder the widespread application of H₂.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.